US FDA orders "black box" suicidality warnings and studies for Chantix and Zyban
02 July 2009
Sue Sutter
The US
FDA has ordered
Pfizer and
GlaxoSmithKline to add "black box" label warnings about serious neuropsychiatric effects for the smoking cessation drugs Chantix (varenicline) and Zyban (bupropion). The companies also must conduct postmarketing clinical trials to determine the incidence of serious...
Please Login to read the full article.
02 July 2009
Sue Sutter
Please Login to read the full article.
RELATED CONTENT
NEWS
- Patchy reimbursement and HTAs leave smoking cessation drugs short of breath
- US Capitol Capsule: Zombies, doomsday and debt ceilings, oh my
- No smoke without fire as Pfizer questions French political ban on Champix
- US FDA panel rejects BMS/AstraZeneca diabetes drug on cancer, liver injury concerns
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
